Literature DB >> 18791731

Does tumor size have an impact on gastric cancer? A single institute experience.

Kyong Hwa Jun1, Hun Jung, Jong Min Baek, Hyung Min Chin, Woo Bae Park.   

Abstract

PURPOSE: The present study investigated the prognostic significance of tumor size in gastric carcinoma patients.
METHODS: Nine hundred seventy-three gastric carcinoma patients who underwent curative gastrectomy were included and hospital records were reviewed to determine the relationship between tumor size and survival.
RESULTS: First, the patients were divided based on the mean value of the tumor size in respective stages to control selection bias. Only in stages I and III was tumor size a significant independent prognostic factor. Second, we analyzed the appropriate cutoff value for the large tumor. The minimum criterion for a large tumor, which was determined by the receiver-operating characteristic curve for cancer-related death, was 3.5 cm. There were significant differences between patients with large and small tumors with respect to depth of invasion, number of lymph node metastasis, and stage of disease.
CONCLUSIONS: Tumor size serves as an indicator of prognosis in gastric cancer patients and a tumor size of 3.5 cm can be used as a significant lower limit of standard size criterion.

Entities:  

Mesh:

Year:  2008        PMID: 18791731     DOI: 10.1007/s00423-008-0417-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  18 in total

1.  Clinicopathological characteristics of superficial spreading type early gastric cancer.

Authors:  Masato Imai; Yukifumi Kondo; Shohei Osawa; Yasunori Nishida; Kuniaki Okada; Hiroyuki Ishizu; Hiroyuki Masuko; Tsunetake Hata; Kazuhito Uemura; Masaya Kina; Shohei Honda; Gentaro Ishiyama; Toru Takahashi; Atsushi Hino
Journal:  J Surg Oncol       Date:  2003-06       Impact factor: 3.454

2.  Determining prognostic factors for gastric cancer using the regression tree method.

Authors:  Yoshitaka Yamamura; Toshifusa Nakajima; Keiichiro Ohta; Atsushi Nashimoto; Kuniyoshi Arai; Masahiro Hiratsuka; Mitsuru Sasako; Yasuhiro Kodera; Masashi Goto
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

3.  Progress in gastric cancer surgery in Japan and its limits of radicality.

Authors:  K Maruyama; K Okabayashi; T Kinoshita
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

4.  The efficacy of gastrectomy for large gastric cancer.

Authors:  Osamu Kobayashi; Akira Tsuburaya; Takaki Yoshikawa; Tomohiko Osaragi; Hitoshi Murakami; Tatsuya Yoshida; Motonori Sairenji
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

5.  Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG).

Authors:  I Songun; H J Keizer; J Hermans; P Klementschitsch; J E de Vries; J A Wils; J van der Bijl; J H van Krieken; C J van de Velde
Journal:  Eur J Cancer       Date:  1999-04       Impact factor: 9.162

6.  Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.

Authors:  Hiroaki Saito; Tomohiro Osaki; Daiki Murakami; Teruhisa Sakamoto; Shingo Kanaji; Shotaro Oro; Shigeru Tatebe; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  Am J Surg       Date:  2006-09       Impact factor: 2.565

7.  Prospective study of peritoneal recurrence after curative surgery for gastric cancer.

Authors:  F Roviello; D Marrelli; G de Manzoni; P Morgagni; A Di Leo; L Saragoni; A De Stefano
Journal:  Br J Surg       Date:  2003-09       Impact factor: 6.939

8.  Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy.

Authors:  K Nakamura; T Ueyama; T Yao; Z X Xuan; K Ambe; Y Adachi; Y Yakeishi; A Matsukuma; M Enjoji
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

9.  Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

Authors:  Atsushi Nashimoto; Toshifusa Nakajima; Hiroshi Furukawa; Masatsugu Kitamura; Taira Kinoshita; Yoshitaka Yamamura; Mitsuru Sasako; Yasuo Kunii; Hisahiko Motohashi; Seiichiro Yamamoto
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

10.  Superficial spreading type of early gastric cancer.

Authors:  K Kitamura; T Yamaguchi; K Okamoto; T Nishida; T Takahashi
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

View more
  9 in total

1.  Can horizontal diameter of colorectal tumor help predict prognosis?

Authors:  Ahmet Ziya Balta; Yavuz Özdemir; İlker Sücüllü; Serhat Tolga Derici; Mahir Bağcı; Dilaver Demirel; Mehmet Levhi Akın
Journal:  Ulus Cerrahi Derg       Date:  2014-09-01

2.  Prognostic significance of host- and tumor-related factors in patients with gastric cancer.

Authors:  Yasuhiko Mohri; Kouji Tanaka; Masaki Ohi; Takeshi Yokoe; Chikao Miki; Masato Kusunoki
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

3.  Is tumor length a prognostic indicator for esophageal squamous cell carcinoma? A single larger study among Chinese patients.

Authors:  Ming-Quan Ma; Zhen-Tao Yu; Peng Tang; Hong-Jing Jiang; Xi-Jiang Zhao; Jian-Guo Zhang; Da-Wang Qu; Qing-Wen Jin; Xi-Zeng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Prognostic value of tumor size in gastric cancer: an analysis of 2,379 patients.

Authors:  Pengtao Guo; Yangming Li; Zhi Zhu; Zhe Sun; Chong Lu; Zhenning Wang; Huimian Xu
Journal:  Tumour Biol       Date:  2013-01-15

5.  Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Rosa Berenato; Luca Turati; Alessia Mennitto; Francesca Steccanella; Marta Caporale; Pierpaolo Dallera; Filippo de Braud; Ezio Pezzica; Maria Di Bartolomeo; Giovanni Sgroi; Vincenzo Mazzaferro; Filippo Pietrantonio; Sandro Barni
Journal:  J Gastrointest Oncol       Date:  2017-02

6.  Minimally invasive surgery for serosa-positive gastric cancer (pT4a) in patients with preoperative diagnosis of cancer without serosal invasion.

Authors:  T Son; W J Hyung; J H Lee; Y M Kim; S H Noh
Journal:  Surg Endosc       Date:  2013-10-23       Impact factor: 4.584

7.  Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.

Authors:  Hong-Mei Wang; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

8.  Tumor size as a prognostic factor in gastric cancer patient.

Authors:  Won Jin Im; Min Gyu Kim; Tae Kyung Ha; Sung Joon Kwon
Journal:  J Gastric Cancer       Date:  2012-09-30       Impact factor: 3.720

9.  Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China.

Authors:  Kongwang Hu; Shuaili Wang; Zikun Wang; Longlong Li; Zhiguo Huang; Weiqiang Yu; Zhongxue Chen; Qing-Fa Wu
Journal:  BMJ Open       Date:  2019-09-20       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.